Announcement on the Completion of Shareholders' Share Reduction Plan
Shenzhen Stock Exchange Code: 301257
Stock Abbreviation: Puris
Announcement Number: 2026-038
Puris (Shanghai) Pharmaceutical Technology Development Co., Ltd. (hereinafter referred to as "the Company") disclosed the "Pre-disclosure Announcement of Shareholders' Share Reduction Plan" on April 14, 2026. Shareholders Xinjiang Tairui Equity Investment Partnership (Limited Partnership) (hereinafter referred to as "Xinjiang Tairui") and its concerted actor, Shanghai Guanyu Investment Development Co., Ltd. - Guanyu Zhaotai (Jiaxing) Venture Capital Partnership (Limited Partnership) (hereinafter referred to as "Guanyu Zhaotai"), planned to reduce their holdings of the Company's shares by no more than 766,467 shares (accounting for 0.97% of the Company's total share capital) and 1,192,800 shares (accounting for 1.51% of the Company's total share capital) respectively, within three months after the announcement of the reduction plan, through block trading and/or centralized bidding. Recently, the Company received notices from shareholders Xinjiang Tairui and Guanyu Zhaotai stating that their share reduction plans have been completed as of the date of this announcement. The relevant information is hereby announced as follows:
1. Implementation of Shareholders' Share Reduction Plan
- Share Reduction Details